Sutro Biopharma
STRO
$11.46+8.94%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$470.77M
EV/Sales
4.03
P/E ratio
N/A
FY2025 Revenue
$102.48M
EPS (TTM)
$-26.64
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-186.45%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported STRO revenue for 2025-12-31 was $102.5M. Net income was -$191.1M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. STRO currently screens at market cap $470.8M.
Use this STRO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full STRO income, balance, and cash tables.
Sutro Biopharma (STRO) is a biotechnology company in the Healthcare sector.
Latest cached Sutro Biopharma (STRO) revenue for Dec 31, 2025 was $102.5M. Net income was -$191.1M. Statements: https://lician.com/financials/stro
Sutro Biopharma (STRO) market capitalization is $470.8M on the latest cached snapshot.
Sutro Biopharma (STRO) cached previous close $10.52; day range $10.54 – $11.46; volume 418,364. Session quote: https://lician.com/quote/stro
Sutro Biopharma (STRO) latest cached earnings event is "STRO earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached STRO filing is 8-K · Aug 12, 2026. Filings: https://lician.com/sec/stro